| Literature DB >> 29323032 |
Abstract
Entities:
Year: 2017 PMID: 29323032 PMCID: PMC5784341 DOI: 10.4103/1673-5374.221151
Source DB: PubMed Journal: Neural Regen Res ISSN: 1673-5374 Impact factor: 5.135
Figure 1An illustration of significantly altered in the VEGF-A pathway after electrical stimulation (George et al., 2017).
VEGF-A: Vascular endothelial growth factor A; CTGF: connective tissue growth factor; THBS1: thrombospondin 1; IGFBP5: insulin-like growth factor binding protein 5; PLAU: plasminogen activator urokinase; PLAT: tissue plasminogen activator; ADAMTS1: a disintegrin and metalloproteinase with thrombospondin motifs 1; TGFB1: transforming growth factor beta 1; CXC12: chemokine 12; MMP13: matrix metallopeptidase 13; MMP9: matrix metallopeptidase 9; COL1A1: collagen type I alpha 1; VASH1: vasohibin 1; SERPINE1: serine proteinase inhibitor family E member 1; CAV1: caveolin 1; NRGN: neurogranin; EFNB2: ephrin B2; UNC5B: un-coordinated-5 homolog B; KDR: kinase domain region receptor; HMOX1: heme oxygenase 1; COX6B1: cytochrome c oxidase subunit 6B1; TMSB10: thymosin beta 10; TMSB4X: thymosin beta 4X; ATP5O: ATP synthase subunit O; GART: glycinamide ribonucleotide transformylase; NRF1: nuclear respiratory factor 1; HIF1A: hypoxia-inducible factor 1 alpha; ETV4: ETS translocation variant 4; CREBBP: cAMP-response element binding protein; CCND1: cyclin D1; LMNA: lamin A/C; RCAN1: regulator of calcineurin 1; PCNA: proliferating cell nuclear antigen; MEOX2: mesenchyme homeobox 2; CDKN1A: cyclin dependent kinase inhibitor 1A.